Fusion Protein Having Enhanced in vivo Activity of Erythropoietin

Details for Australian Patent Application No. 2002300359 (hide)

Owner Cheil Jedang Corporation

Inventors Kim, Ki-Wan; Park, Ji-Sook; Chung, BoSup; Oh, Myung-Suk; Lee, Dong-Eok

Agent Spruson & Ferguson

Pub. Number AU-B-2002300359

Priority 2001-74975 29.11.01 KR

Filing date 30 July 2002

Wipo publication date 12 June 2003

Acceptance publication date 23 December 2004

International Classifications

C07K 019/00 Hybrid peptides

C12N 015/62 Mutation or genetic engineering - DNA sequences coding for fusion proteins

C07K 014/52 Peptides having more than 20 amino acids

C12N 015/12 Mutation or genetic engineering - Genes encoding animal proteins

C07K 014/505 Peptides having more than 20 amino acids

Event Publications

12 June 2003 Application Open to Public Inspection

  Published as AU-B-2002300359

23 December 2004 Application Accepted

  Published as AU-B-2002300359

21 April 2005 Standard Patent Sealed

24 April 2008 Assignment Registered

  Cheil Jedang Corporation The patent has been assigned to CJ CheilJedang Corp. Assignments Registered

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002300360-Paper roll holder and dispenser

2002300358-Three-dimensional Imaging System